Search Results - "Schoser, B. G."

Refine Results
  1. 1

    Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited by Schoser, B. G. H., Müller-Höcker, J., Horvath, R., Gempel, K., Pongratz, D., Lochmüller, H., Müller-Felber, W.

    Published in Neuropathology and applied neurobiology (01-10-2007)
    “…The need for clinical awareness and diagnostic precision of glycogen storage disease type 2 (GSD2) has increased, as enzyme replacement therapy has become…”
    Get full text
    Journal Article
  2. 2

    Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers by Schoser, B. G. H., Blottner, D., Stuerenburg, H.-J.

    Published in Acta neurologica Scandinavica (01-04-2002)
    “…Objectives– To further examine the role of proteolytic enzyme expression of matrix metalloproteinases (MMP) and T‐cell markers in inflammatory myopathies and…”
    Get full text
    Journal Article
  3. 3

    Serum levels of matrix metalloproteinases-2 and -9 and their tissue inhibitors in inflammatory neuromuscular disorders by Hurnaus, S, Mueller-Felber, W, Pongratz, D, Schoser, B G H

    Published in European neurology (01-08-2006)
    “…We monitored serum levels of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) before and during intravenously applied immunoglobulin (IVIG)…”
    Get more information
    Journal Article
  4. 4

    Molecular biomarkers monitoring human skeletal muscle fibres and microvasculature following long‐term bed rest with and without countermeasures by Salanova, M., Schiffl, G., Püttmann, B., Schoser, B. G., Blottner, D.

    Published in Journal of anatomy (01-03-2008)
    “…The cellular mechanisms of human skeletal muscle adaptation to disuse are largely unknown. The aim of this study was to determine the morphological and…”
    Get full text
    Journal Article
  5. 5

    Matrix metalloproteinases MMP-2, MMP-7 and MMP-9 in denervated human muscle by Schoser, Benedikt G. H, Blottner, D

    Published in Neuroreport (09-09-1999)
    “…PROTEOLYTIC enzyme expression was studied by matrix metalloproteinases (MMP) immunoreactivity (-IR) in muscle biopsies from patients with amyotrophic lateral…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Coenzyme Q10 deficiency and isolated myopathy by HORVATH, R, SCHNEIDERAT, P, LOCHMÜLLER, H, SCHOSER, B. G. H, GEMPEL, K, NEUEN-JACOB, E, PLÖGER, H, MÜLLER-HÖCKER, J, PONGRATZ, D. E, NAINI, A, DIMAURO, S

    Published in Neurology (24-01-2006)
    “…Three unrelated, sporadic patients with muscle coenzyme Q10 (CoQ10) deficiency presented at 32, 29, and 6 years of age with proximal muscle weakness and…”
    Get full text
    Journal Article
  8. 8

    Sudden cardiac death in myotonic dystrophy type 2 by SCHOSER, B. G. H, RICKER, K, SCHNEIDER-GOLD, C, HENGSTENBERG, C, DÜRRE, J, BÜLTMANN, B, KRESS, W, DAY, J. W, RANUM, L. P. W

    Published in Neurology (28-12-2004)
    “…Medical records and follow-up data were reviewed in 297 genetically proven myotonic dystrophy type 2 (DM2) patients. Patients were selected by the criteria of…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Outcome and effect of pregnancy in myotonic dystrophy type 2 by RUDNIK-SCHÖNEBORN, S, SCHNEIDER-GOLD, C, RAABE, U, KRESS, W, ZERRES, K, SCHOSER, B. G. H

    Published in Neurology (28-02-2006)
    “…The authors reviewed the obstetric histories of 42 women of 37 families with myotonic dystrophy type 2 (DM2). Nine women (21%) had the first symptoms during…”
    Get full text
    Journal Article
  14. 14

    McLeod myopathy revisited: more neurogenic and less benign by Hewer, Ekkehard, Danek, Adrian, Schoser, Benedikt G., Miranda, Marcelo, Reichard, Ross, Castiglioni, Claudia, Oechsner, Matthias, Goebel, Hans H., Heppner, Frank L., Jung, Hans H.

    Published in Brain (London, England : 1878) (01-12-2007)
    “…The X-linked McLeod neuroacanthocytosis syndrome (MLS) has originally been denoted as ‘benign’ McLeod myopathy. We assessed the clinical findings and the…”
    Get full text
    Journal Article
  15. 15

    CD95-mediated apoptosis and DNA fragmentation in MS by Heesen, C., Georghiu, S., Gbadamosi, J., Schoser, B. G. H.

    Published in Acta neurologica Scandinavica (01-11-2000)
    “…Objective– To investigate possible associations of soluble CD95 (sCD95) serum levels and DNA defragmentation with different MS disease stages and activities…”
    Get full text
    Journal Article
  16. 16

    Mutations in the acid α-glucosidase gene (M. Pompe) in a patient with an unusual phenotype by ANNESER, J. M. H, PONGRATZ, D. E, PODSKARBI, T, SHIN, Y. S, SCHOSER, B. G. H

    Published in Neurology (25-01-2005)
    “…Glycogenosis type II (Pompe disease) is a lysosomal storage disease caused by deficiency of acid alpha-glucosidase (acid maltase). The disease is autosomal…”
    Get full text
    Journal Article
  17. 17

    A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation by VORGERD, M, RICKER, K, ZIEMSSEN, F, KRESS, W, GOEBEL, H. H, NIX, W. A, KUBISCH, C, SCHOSER, B. G. H, MORTIER, W

    Published in Neurology (26-12-2001)
    “…To determine the cause of sporadic rippling muscle disease (RMD) in a 24-year-old patient. RMD is a rare myopathy characterized by percussion-induced rapid…”
    Get full text
    Journal Article
  18. 18

    The impact of raised intracranial pressure on cerebral venous hemodynamics : a prospective venous transcranial Doppler ultrasonography study by SCHOSER, B. G. H, RIEMENSCHNEIDER, N, HANSEN, H. C

    Published in Journal of neurosurgery (01-11-1999)
    “…The effect of increased intracranial pressure (ICP) on cerebral venous blood flow has been the subject of very few clinical and experimental studies. The…”
    Get full text
    Journal Article
  19. 19

    Brain imaging and neuropsychology in late-onset dementia due to a novel mutation (R93C) of valosin-containing protein by Krause, S, Göhringer, T, Walter, M C, Schoser, B G H, Reilich, P, Linn, J, Pöpperl, G E, Frölich, L, Hentschel, F, Lochmüller, H, Danek, A

    Published in Clinical neuropathology (01-09-2007)
    “…Inclusion body myopathy with Paget disease of bone and frontotemporal dementia (IBMPFD, MIM 167320) is a recently identified autosomal dominant disorder due to…”
    Get more information
    Journal Article
  20. 20

    Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease by Van den Bergh, P Y K, Gérard, J M, Elosegi, J A, Manto, M U, Kubisch, C, Schoser, B G H

    “…Rippling muscle disease (RMD) is a rare muscle disorder characterised by muscle stiffness, exercise induced myalgia, and cramp-like sensations. It is…”
    Get full text
    Journal Article